European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. Let’s find out!

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

SEPTEMBER 30, 2024

This article outlines how developers can utilize sustainability initiatives to boost revenue, reduce costs, and advance innovation, ensuring a strategic, long-term, and more sustainable position in today’s competitive landscape. Continued innovation is crucial in enhancing sustainability within pharma and the broader biotech industry.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

European Pharmaceutical Review

DECEMBER 6, 2023

What trends are you seeing in the pharma space? Packaging solutions for track and trace are becoming increasingly important and can be considered emerging trends” Next is ensuring end-to-end connectivity of information from the point of manufacture to when it reaches the customer. These are key areas that are always on trend.

Manufacturing 98

Manufacturing Engineering Pharmaceutical manufacturing Pharmaceutical 98

pharmaphorum

NOVEMBER 25, 2022

Having a healthy and sustainable pharmaceutical sector is both a necessary requirement and a good one for society. Talking about the integrated supply chain that is always in play with France and Germany, he warned of continuous competition that could pose a gradual risk to Italy’s research basis in development research.

Pharmaceutical 93

Pharmaceutical Manufacturing Medicine Competition 93

Pharmaceutical Technology

JULY 29, 2022

This is borne out of the fact that while nearly three-quarters are confident in the education and training for those in the pharma sector, just 64% are confident with the industry’s ability to source engineers against competition from other sectors. Manufacturing agility: Index score 6.5/10.

Biopharma 59

Biopharma Manufacturing Government Engineering 59

Contrarian Sales Techniques

FEBRUARY 26, 2023

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% However, they face increasing competition from foreign generic drug suppliers, which have established themselves in the market for public tenders.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

Pharmaceutical Technology

MARCH 22, 2023

In light of the Covid-19 pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for onshoring, also referred to as reshoring; the bringing back of pharma production to locations within national borders to mitigate costs, supply issues, and concerns regarding bilateral relations.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Government Pharmaceutical 105

Pharmaceutical Technology

FEBRUARY 15, 2023

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.

Pharma 52

Pharma Pharmaceutical Manufacturing Medicine 52

Pharmaceutical Technology

DECEMBER 19, 2022

Pierre Socha, partner at Amadeus Capital Partners, London, UK, predicts that larger pharmaceutical companies may have similar interests. Most pharmas will buy biotech companies or smaller pharma groups for the quality of their clinical assets and the drugs on their developments,” he says.

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69

Clarivate

AUGUST 20, 2024

Top-line differences between list price and MFP obscure the impact of discounts and rebates that PBMs and MCOs can secure from manufacturers in exchange for coverage or preferred access. In highly competitive categories like diabetes, net price could be half of the list price.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52